Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2025-12-25 @ 2:44 AM
NCT ID:
NCT02924233
Eligibility Criteria:
Main Inclusion Criteria:
* Signed and dated written informed consent
* Male or female ≥18 years of age at the time of informed consent
* Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
* Life expectancy \>3 months assessed during Screening
* Histologically or cytologically confirmed, locally advanced or metastatic squamous NSCLC
Main Exclusion Criteria:
* Any antineoplastic agent (standard or investigational) within 2 weeks prior to starting trial treatment
* Radiosurgery or radiotherapy for target lesions within 2 weeks prior to starting trial treatment
* Prophylactic use of hematopoietic growth factors within 1 week prior to starting trial treatment
* Active Central Nervous System (CNS) metastases or carcinomatous meningitis
* Women who are pregnant
* Women who are breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02924233
Study Brief:
Protocol Section:
NCT02924233